Stocks Health care OMDA
NASDAQ · Health careOmada Health, Inc. (OMDA)
Omada Health, Inc. brought in $333M of revenue over the twelve months to September 30, 2026. Net income was $14M, a net margin of 4.2%. Operating cash flow minus capital spending left $16.9M of free cash flow in fiscal 2025. At September 30, 2026 it held $243.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 6, 2026.
Key facts about Omada Health, Inc.
- Net worth
- Omada Health, Inc. has a market value (market cap) of $909.1M at the latest share price, and shareholders' equity of $273.2M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $260.2M (+53.2% year on year), with a net loss of $12.8M. Over the 12 months to September 30, 2026: revenue $333M, net income $14M.
- Cash flow
- In fiscal 2025 operations brought in $18.3M of cash; after $1.3M of capital spending, free cash flow was $16.9M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 6, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Omada Health, Inc.'s next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Omada Health, Inc. does
Omada Health, Inc. is registered with the SEC under industry code SIC 8000 (Services-Health Services). Its shares trade on NASDAQ under the ticker OMDA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $260.2M | -$12.8M | -$0.35 | $16.9M |
| 2025 | $169.8M | -$47.1M | -$6.11 | -$34.8M |
| 2023 | $122.8M | -$67.5M | -$9.52 | -$50.2M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where OMDA ranks in Health care
Latest SEC filings
What Omada Health, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 6, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 34% to $91.3M versus the same quarter last year; diluted EPS $0.10 versus -$0.06.
- November 5, 2026
- November 5, 2026Passive stake changed SCHEDULE 13G/A
- November 2, 2026Passive stake changed SCHEDULE 13G/A
- October 27, 2026Passive stake (5% or more) SCHEDULE 13G
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 7, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 43% to $87.8M versus the same quarter last year; diluted EPS $0.08 versus -$0.24.
- August 6, 2026
- June 23, 2026Passive stake (5% or more) SCHEDULE 13G
What is OMDA worth? A DCF from its reported cash flow
Insider trades
What the people running Omada Health, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $1.7M worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 4, 2026 | Duffy Sean P.Chief Executive Officer, Director | Exercised options | 12,944 | $75.3K |
| November 4, 2026 | Duffy Sean P.Chief Executive Officer, Director | Soldpre-planned (10b5-1) | 12,944 | $248.7K |
| October 5, 2026 | Hilleman Jeryl LDirector | Received as pay | 1,214 | - |
| October 5, 2026 | Fetter TrevorDirector | Received as pay | 751 | - |
| October 5, 2026 | Klapstein Julie DDirector | Received as pay | 549 | - |
| October 5, 2026 | Root Jonathan DDirector | Received as pay | 694 | - |
| October 1, 2026 | Duffy Sean P.Chief Executive Officer, Director | Exercised options | 12,944 | $75.3K |
| October 1, 2026 | Duffy Sean P.Chief Executive Officer, Director | Exercised options | 4,314 | $35.7K |
Who owns OMDA
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Divisadero Street Capital Management, LP13G, passive with 4 related filers | 6.3% | August 14, 2026 |
| American Century Investment Management, Inc.13G, passive with 2 related filers | 6.2% | August 14, 2026 |
| BlackRock, Inc.13G, passive | 6% | October 27, 2026 |
| The Cigna Group13G, passive with 1 related filers | 5.8% | June 23, 2026 |
| Fmr LLC13G, passive with 1 related filers | 5.6% | May 6, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 154 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Revelation Capital Management, LLC | 4,858,034 | -350,000 |
| Divisadero Street Capital Management, LP | 3,799,695 | -2,088,020 |
| American Century Companies Inc | 3,678,676 | +1,222,367 |
| Morgan Stanley | 2,800,887 | +1,334,111 |
| Fmr LLC | 2,775,102 | -513,278 |
| Nvp Associates, LLC | 2,531,000 | 0 |
| BlackRock, Inc. | 2,222,074 | +317,516 |
| Vanguard Capital Management LLC | 1,926,594 | +117,610 |
| Millennium Management LLC | 1,724,057 | +620,062 |
| Loomis Sayles & Co L P | 1,598,787 | -113,989 |
| D. E. Shaw & Co., Inc. | 1,202,058 | +1,047,066 |
| a16z Capital Management, L.L.C. | 1,153,639 | -1,153,645 |
| Oberweis Asset Management Inc/ | 1,048,800 | new |
| Nuveen, LLC | 950,724 | +911,264 |
| Arrowstreet Capital, Limited Partnership | 843,583 | +752,561 |
| Archon Capital Management LLC | 790,994 | +65,874 |
| Perceptive Advisors LLC | 786,330 | 0 |
| Jefferies Financial Group Inc. | 684,091 | -124,900 |
| State Street Corp | 611,056 | +62,584 |
| Point72 Asset Management, L.P. | 597,997 | -308,210 |
Insiders
11 insiders reported holding 1,196,205 shares in total, about $17.8M at the last price.
| Holder | Shares |
|---|---|
| Duffy Sean P.Chief Executive Officer, Director | 382,594 |
| Shao Wei-LiPresident | 295,313 |
| Root Jonathan DDirector | 192,571 |
| Cook Steven L.Chief Financial Officer | 173,906 |
| Hilleman Jeryl LDirector | 27,869 |
| Fetter TrevorDirector | 25,172 |
| Klapstein Julie DDirector | 22,514 |
| Stavisky AdamDirector | 20,618 |
| Beal AnneDirector | 20,618 |
| Jain Sachin H.Director | 20,618 |
Questions about OMDA
What does Omada Health, Inc. do?
Omada Health, Inc. is a company in the Health care sector, listed on NASDAQ as OMDA. Its shares trade on NASDAQ under the ticker OMDA.
What is Omada Health, Inc.'s net worth?
Omada Health, Inc. has a market value (market cap) of $909.1M at the latest share price, and shareholders' equity of $273.2M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Omada Health, Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $14M on revenue of $333M, a net margin of 4.2%.
How much revenue does Omada Health, Inc. make?
Over the twelve months to September 30, 2026 Omada Health, Inc. reported revenue of $333M.
When did Omada Health, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 6, 2026. It covers the period to September 30, 2026.
When is Omada Health, Inc.'s next earnings report?
Omada Health, Inc.'s next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare OMDA with
Follow OMDA
Get an email when Omada Health, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Omada Health, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.